Pricing & Commercialization Strategy
For medical device and SaMD companies, pricing shapes reimbursement expectations, influences payer coverage decisions, and determines whether a technology reaches the patients who need it. Getting it wrong at launch can undermine years of development — and limit patient access before a product ever reaches scale.
We integrate pricing strategy directly into the broader reimbursement and commercialization framework — ensuring that what you charge aligns with what payers will support and what the market will sustain.
From early-stage scenario modeling to full commercialization roadmap integration, our work ensures pricing decisions are never made in isolation from the coverage and payment environment your technology will enter.
Pricing Strategy & Scenario Modeling
Developing pricing frameworks that account for reimbursement realities, care setting dynamics, and adoption trajectories across your target markets.
Competitive Benchmarking & Market Analysis
Evaluating the competitive landscape, comparable technology pricing, and payer expectations to position your technology for both access and long-term viability.
Market Adoption Analysis
Assessing the factors that drive or impede adoption — including reimbursement rates, coding alignment, and provider incentives — and building strategies to accelerate uptake.
Commercialization Roadmap Integration
For companies at or approaching launch, we align pricing strategy with your full commercialization plan — ensuring cohesion across coding, coverage, payment, and market entry. This is not a one-time deliverable. We work alongside your team to ensure pricing decisions remain aligned with the evolving reimbursement environment as your technology scales.
Build a pricing strategy that performs in the market.
Let's talk about where you are in your commercialization journey and how Prevara can help you price and position for sustainable access.
Get In Touch →